1. Home
  2. TMDX vs OI Comparison

TMDX vs OI Comparison

Compare TMDX & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • OI
  • Stock Information
  • Founded
  • TMDX 1998
  • OI 1903
  • Country
  • TMDX United States
  • OI United States
  • Employees
  • TMDX N/A
  • OI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • OI Containers/Packaging
  • Sector
  • TMDX Health Care
  • OI Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • OI Nasdaq
  • Market Cap
  • TMDX 4.8B
  • OI 2.2B
  • IPO Year
  • TMDX 2019
  • OI N/A
  • Fundamental
  • Price
  • TMDX $128.97
  • OI $15.12
  • Analyst Decision
  • TMDX Buy
  • OI Buy
  • Analyst Count
  • TMDX 10
  • OI 8
  • Target Price
  • TMDX $127.33
  • OI $15.88
  • AVG Volume (30 Days)
  • TMDX 838.7K
  • OI 1.8M
  • Earning Date
  • TMDX 07-30-2025
  • OI 07-29-2025
  • Dividend Yield
  • TMDX N/A
  • OI N/A
  • EPS Growth
  • TMDX N/A
  • OI N/A
  • EPS
  • TMDX 1.41
  • OI N/A
  • Revenue
  • TMDX $488,227,000.00
  • OI $6,505,000,000.00
  • Revenue This Year
  • TMDX $34.07
  • OI $1.90
  • Revenue Next Year
  • TMDX $20.76
  • OI $1.28
  • P/E Ratio
  • TMDX $92.35
  • OI N/A
  • Revenue Growth
  • TMDX 64.43
  • OI N/A
  • 52 Week Low
  • TMDX $55.00
  • OI $9.23
  • 52 Week High
  • TMDX $177.37
  • OI $15.58
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 59.35
  • OI 61.42
  • Support Level
  • TMDX $120.36
  • OI $14.64
  • Resistance Level
  • TMDX $133.49
  • OI $15.58
  • Average True Range (ATR)
  • TMDX 5.58
  • OI 0.43
  • MACD
  • TMDX -1.35
  • OI 0.07
  • Stochastic Oscillator
  • TMDX 60.26
  • OI 62.84

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: